Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 250

Results For "API"

2532 News Found

GlaxoSmithKline approves sale of Vemgal plant
News | April 05, 2021

GlaxoSmithKline approves sale of Vemgal plant

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS


Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities
News | April 05, 2021

Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities

ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E


Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
News | April 05, 2021

Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI

TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India


Reports on GSK Pharmaceuticals by ICICI Securities
News | April 03, 2021

Reports on GSK Pharmaceuticals by ICICI Securities

GSKP announced sale of its newly constructed manufacturing plant at Vemgal, Karnataka to Hetero Labs for a cash consideration of Rs1.8bn


Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr
News | April 01, 2021

Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr

This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs


Biocon partners with Libbs to launch generic formulations in Brazil
Biotech | March 30, 2021

Biocon partners with Libbs to launch generic formulations in Brazil

Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil to import, distribute and market


COVID-19 drug Remdesivir now priced at Rs. 899
News | March 25, 2021

COVID-19 drug Remdesivir now priced at Rs. 899

Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection.


Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
News | March 18, 2021

Merck accelerates expansion plans for single-use products critical to manufacturing vaccines

The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.


Govt. receives 215 applications for the 36 products under PLI scheme
News | March 13, 2021

Govt. receives 215 applications for the 36 products under PLI scheme

174 applications were received for 23 eligible products under Target Segment IV - Other Chemical Synthesis Based KSMs/ Drug Intermediates/APIs.


Aarti Speciality Chemicals receives PLI approval for pharmaceutical sector
News | March 08, 2021

Aarti Speciality Chemicals receives PLI approval for pharmaceutical sector

The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.